Stocks & Investing
Mon, November 21, 2022
[ 12:00 AM ] - WOPRAI
Mon, October 31, 2022
[ 12:00 AM ] - WOPRAI
Mon, August 1, 2022
[ 12:00 AM ] - WOPRAI
Wed, July 27, 2022
[ 12:00 AM ] - WOPRAI
Mon, July 25, 2022
[ 12:00 AM ] - WOPRAI
Fri, March 4, 2022
[ 12:00 AM ] - WOPRAI
Tue, February 8, 2022
[ 12:00 AM ] - WOPRAI
Thu, November 4, 2021
[ 12:00 AM ] - WOPRAI
Wed, November 3, 2021
[ 12:00 AM ] - WOPRAI
Fri, October 15, 2021
[ 12:00 AM ] - WOPRAI
Thu, August 26, 2021
[ 12:00 AM ] - WOPRAI
Mon, August 9, 2021
[ 12:00 AM ] - WOPRAI
Thu, July 29, 2021
[ 12:00 AM ] - WOPRAI
Fri, July 23, 2021
[ 12:00 AM ] - WOPRAI
Thu, June 10, 2021
[ 12:00 AM ] - WOPRAI
Mon, May 24, 2021
[ 12:00 AM ] - WOPRAI
Wed, April 28, 2021
[ 12:00 AM ] - WOPRAI
Thu, July 30, 2020
[ 12:00 AM ] - WOPRAI
Mon, June 15, 2020
[ 12:00 AM ] - WOPRAI
Wed, March 11, 2020
[ 12:00 AM ] - WOPRAI
Mon, March 19, 2018
Tue, February 27, 2018
Wed, November 2, 2016
Mon, May 19, 2014
[ 12:00 AM ] - WOPRAI
Mon, October 21, 2013 Frank Morgan Downgraded (AVAH) to Hold and Decreased Target to $3 on, Nov 21st, 2022
Frank Morgan of RBC Capital, Downgraded "Aveanna Healthcare Holdings Inc." (AVAH) to Hold and Decreased Target from $7 to $3 on, Nov 21st, 2022.
Frank has made no other calls on AVAH in the last 4 months.
There are 5 other peers that have a rating on AVAH. Out of the 5 peers that are also analyzing AVAH, 3 agree with Frank's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- A.J. Rice of "Credit Suisse" Downgraded from Buy to Hold and Decreased Target to $2 on, Thursday, November 17th, 2022
- Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $1.5 on, Friday, November 11th, 2022
- Brian Tanquilut of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $2.5 on, Friday, July 22nd, 2022
These are the ratings of the 2 analyists that currently disagree with Frank
- John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $4 on, Wednesday, November 16th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $5 on, Friday, August 19th, 2022
